Atom Investors LP Ligand Pharmaceuticals Inc Transaction History

Atom Investors LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$49.57 - $72.63 $8,476 - $12,419	-171 Reduced 3.31%	4,999 $357,000
Q3 2023 Nov 14, 2023	SELL	$58.86 - $72.67 $5,827 - $7,194	-99 Reduced 1.88%	5,170 $309,000
Q2 2023 Aug 14, 2023	SELL	$69.53 - $79.33 $227,084 - $259,091	-3,266 Reduced 38.27%	5,269 $379,000
Q1 2023 May 15, 2023	BUY	$65.67 - $77.08 $245,474 - $288,125	3,738 Added 77.92%	8,535 $627,000
Q4 2022 Feb 14, 2023	SELL	$61.72 - $96.74 $348,903 - $546,871	-5,653 Reduced 54.1%	4,797 $320,000
Q1 2022 May 16, 2022	SELL	$94.99 - $151.56 $2,184 - $3,485	-23 Reduced 0.22%	10,450 $1.18 Million
Q4 2021 Feb 14, 2022	SELL	$127.69 - $165.85 $156,675 - $203,497	-1,227 Reduced 10.49%	10,473 $1.62 Million
Q3 2021 Nov 15, 2021	SELL	$102.33 - $144.73 $203,534 - $287,867	-1,989 Reduced 14.53%	11,700 $1.63 Million
Q2 2021 Aug 16, 2021	SELL	$113.03 - $155.64 $298,738 - $411,356	-2,643 Reduced 16.18%	13,689 $1.8 Million
Q1 2021 May 17, 2021	SELL	$99.52 - $215.83 $6.18 Million - $13.4 Million	-62,146 Reduced 79.19%	16,332 $2.49 Million
Q4 2020 Feb 16, 2021	BUY	$80.55 - $106.05 $2.98 Million - $3.92 Million	36,993 Added 89.17%	78,478 $7.81 Million
Q3 2020 Nov 13, 2020	BUY	$89.56 - $126.72 $1.79 Million - $2.53 Million	19,954 Added 92.68%	41,485 $3.95 Million
Q2 2020 Aug 14, 2020	BUY	$68.28 - $123.65 $1.47 Million - $2.66 Million	21,531 New	21,531 $2.41 Million

255

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.82B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.